Prothena Corporation PLC
NASDAQ:PRTA

Watchlist Manager
Prothena Corporation PLC Logo
Prothena Corporation PLC
NASDAQ:PRTA
Watchlist
Price: 15.4 USD 0.46%
Market Cap: 828.7m USD
Have any thoughts about
Prothena Corporation PLC?
Write Note

Prothena Corporation PLC
Investor Relations

Prothena Corp. Plc is a clinical-stage neuroscience company. The firm is engaged in the protein dysregulation and a pipeline of therapeutics for devastating neurodegenerative and rare peripheral amyloid diseases. The company is advancing a pipeline of therapeutic candidates around neurological dysfunction and the biology of misfolded proteins. The firm's clinical pipeline of antibody-based product candidates targets a range of indications, including Birtamimab for the treatment of amyloid light-chain (AL) amyloidosis; prasinezumab for the treatment of Parkinson’s disease and other related synucleinopathies; and PRX004, for the treatment of Transthyretin amyloidosis (ATTR). The firm's pipeline also includes late-preclinical-stage programs targeting proteins implicated in neurological diseases including tau and amyloid beta (Aβ) for the treatment of Alzheimer’s disease and other neurodegenerative disorders, and TDP-43 for the treatment of amyotrophic lateral sclerosis.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Dr. Gene G. Kinney Ph.D.
President, CEO & Director
No Bio Available
Mr. Tran B. Nguyen M.B.A.
CFO & Chief Strategy Officer
No Bio Available
Mr. Brandon S. Smith
Chief Operating Officer
No Bio Available
Ms. Carol D. Karp
Chief Regulatory Officer
No Bio Available
Ms. Karin L. Walker CPA
Chief Accounting Officer & Controller
No Bio Available
Dr. Wagner M. Zago Ph.D.
Chief Scientific Officer
No Bio Available
Mr. Mark C. Johnson C.F.A.
Vice President of Investor Relations
No Bio Available
Mr. Michael J. Malecek
Chief Legal Officer
No Bio Available
Mr. David A. Ford
Chief People Officer
No Bio Available
Dr. Chad J. Swanson Ph.D.
Chief Development Officer
No Bio Available

Contacts

Address
DUBLIN
77 Sir John Rogersons Quay, Block C, Grand Canal Docklands
Contacts
+35312362500.0
www.prothena.com